Overall Technical outlook

Price Summary

On 2025-10-16, Aurobindo Pharma Limited's shares started at 1113.1, peaked at 1116.7, bottomed out at 1098.2, and ended -0.61% lower at 1106.3, with 1710776 shares traded.
The highest price the stock achieved in the past 52 weeks is 1472.7, while the lowest price it saw is 1022.2.
The price outlook for AUROPHARMA is between 730.0 and 1930.0, with an average expectation of 1298.25, as estimated by 28 analysts.

Technicals

Support and Resistance: The price is currently at 1106.3, supported by 1101.4 and resisted by 1143.8. This indicates a range where 1101.4 may provide a base for the price, while 1143.8 serves as a cap on further upward movement for AUROPHARMA.
AUROPHARMA supportResistance a2f167
Support/Resistance for AUROPHARMA


Aroon: The current state of the AROON is neutral for AUROPHARMA, providing no clear indication of a trend in either direction. This suggests that the market may be lacking momentum, making it difficult to predict future movements.
AUROPHARMA aroon a2f167
Aroon chart for Aurobindo Pharma Limited


Bol. Bands: The current reading of the BOLL BANDS indicator suggests a neutral stance, with no clear signals indicating an upward or downward direction. This lack of directional bias suggests the market may be in a period of consolidation or uncertainty.
AUROPHARMA bbands a2f167
Bolinger Bands chart for Aurobindo Pharma Limited


Parabolic SAR: The PSAR maintains its bullish stance, setting a significant support level that could help sustain the market's upward movement. This strong support suggests that Aurobindo Pharma Limited is likely to continue trending higher, providing investors with confidence in the ongoing bullish momentum.
AUROPHARMA psar a2f167
Parabolic Stop and Reverse chart for Aurobindo Pharma Limited


Stochastic: The STOCHASTIC is in a neutral stance, with no clear signals for movement up or down. This neutral position indicates a potential period of consolidation or uncertainty in the market.
AUROPHARMA stoch a2f167
Stochastic chart for Aurobindo Pharma Limited


Tripple Moving Agerage: The Tripple MOVING AVG is currently neutral, showing no clear bias toward a rising or falling trend. This lack of directional clarity suggests that the market may be in a holding pattern, awaiting further developments.
AUROPHARMA trippleSMA a2f167
Tripple SMA chart for Aurobindo Pharma Limited


When evaluating a company's technical indicators like price trends and trading volume, it's important to also assess its fundamentals. Key factors include the company's profitability, growth rate, and financial stability. Furthermore, considering the industry within which the company operates provides additional context, as factors like competition and market demand can affect performance. By combining this analysis, you can make more informed judgments about the company's future prospects.